Properties
Description
AT7519 trifluoroacetate is an CDK kinase inhibitor that disrupts cell division processes. It targets Cdk1/cyclin B, cdk2/cyclin A, Cdk4/cyclin D1, and CDK5/p35.
Molecular Formula
C18H18Cl2F3N5O4
Targets
Cdk1/cyclin B: 210 nM; cdk2/cyclin A: 47 nM; Cdk4/cyclin D1: 100 nM; CDK5/p35: 13 nM
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
AT7519 trifluoroacetate can be utilized in research on the inhibition of multiple CDKs and its therapeutic potential.